Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03227991 · ClinicalTrials.gov registry record · NA
Safety Planning Intervention to Reduce Short Term Risk
A NA study, sponsored by New York State Psychiatric Institute.
- Completed
- Registry status
- NA
- Development phase
- 422
- Enrollment target
NCT03227991: Completed NA study, sponsored by New York State Psychiatric Institute.
NCT03227991 is a NA study that has completed, run by New York State Psychiatric Institute. The registered enrollment target is 422 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (70% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03227991, a NA study, has completed, sponsored by New York State Psychiatric Institute.
- COMPLETED
- Registry status
- NA
- Development phase
- 422 participants
- Enrollment target
Study Summary
This study will determine the efficacy of Safety Planning Intervention (SPI) compared to receiving risk factors and warning sign information (RWI) in recent suicide attempters during the 6 months following an acute care visit on: (1) suicidal behaviors; (2) mental health/substance use treatment engagement; (3) suicide-related coping strategies; (4) suicidal ideation; and (5) use of means restriction.
Primary Outcome
As measured by the Columbia Suicide Severity Rating Scale (C-SSRS); responses are yes-no with yes more severe
Interventions
- BEHAVIORAL Safety Planning Intervention
- BEHAVIORAL Risk factors and Warning signs
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 422 participants |
| Start Date | 2017-09-10 |
| Est. Completion | 2020-06-30 |
| Phase | NA |
What the finished NCT03227991 record still lists
NCT03227991 is an interventional study that assigns participants to a tested intervention. The registered 422 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (70% lower).
The record links to 0 conditions, and to 2 interventions - of which Safety Planning Intervention is the first listed.
NCT03227991 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03227991 about?
NCT03227991 is a clinical study titled "Safety Planning Intervention to Reduce Short Term Risk". This study will determine the efficacy of Safety Planning Intervention (SPI) compared to receiving risk factors and warning sign information (RWI) in recent suicide attempters during the 6 months following an acute care visit on: (1) suicidal behaviors; (2) mental health/substance use treatment enga...
What is the current status of trial NCT03227991?
This trial is currently completed. It is a NA study. The enrollment target is 422 participants. The study started on 2017-09-10. Estimated completion is 2020-06-30.
What interventions are being tested in trial NCT03227991?
The interventions under investigation include: Safety Planning Intervention (BEHAVIORAL), Risk factors and Warning signs (BEHAVIORAL).
Who is sponsoring clinical trial NCT03227991?
This trial is sponsored by New York State Psychiatric Institute, which has 364 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03227991's enrollment target sits among peer trials
422 238th of 2000 higher than 1,762 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04763356 · 422 participants · NA
Remote Monitoring and Management of Chemotherapy Induced Peripheral Neuropathy
- NCT06837246 · 422 participants · NA
A Clinical Trial to Assess Cognitive Effects of Cognitive Nutritional Supplement in General Population
- NCT07298967 · 422 participants · NA
ORCHARDS-AIR Study
- NCT06935591 · 423 participants · NA
Artificial Intelligence Mapping and Ablation of Non-Pulmonary Vein Electrical Drivers of AF Study
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI